Newsletters
Private Equity's Expansion into Cardiology, the Impact of Bundled Payments, and Risk Adjustment in Medicare Advantage
Explore the latest findings from CAHPR on the growing PE interest in cardiology, UnitedHealthcare's ASC acquisitions, significant price disparities in hospital services, the limited impact of the End-Stage Renal Disease Treatment Choices model, and the financial challenges faced by MA enrollees, and more on health policy issues faced by the nation - July 2024
Effect of Hospital Price Caps, Tackling PE Influence, and Unveiling Medicare Disparities
This newsletter highlights our featured research of the quarter on the impact of hospital price caps in the state of Oregon. Other research and policy highlighted include the lifecycle of private equity investments in physician practices, ramifications of hospital-physician integration on primary care access, and characterizing beneficiary access and behavior in Medicare - April 2024
Billions in Medicare Overpayments, High Rates of MA Disenrollement, and the COVID-19 Impact
Research from CAHPR unravel the complexities of Medicare Advantage payments and the broader impacts of the COVID-19 pandemic on public health strategies and healthcare workforce dynamics - January 2024
Improving Medicare Advantage
As the annual update on proposed payment rates and policies for MA unfolds, attention intensifies around initiatives aimed at improving the MA program. CAHPR identifies gaps in the current MA programs and offers potential legislative and regulatory reforms designed to enhance the MA program, drawing on robust, evidence-based policy research - January 2024
Medicare Advantage and Private Equity
CAHPR investigators expose significant overpayments to MA due to favorable selection, concerns about MA network adequacy for the most vulnerable populations, and the impact of private equity acquisitions on Medicare spending - October 2023